All Good manufacturing practice (GMP) articles
-
JournalVM4: The latest EU and international developments in Good Manufacturing Practice
This is a report of the VM4 session that took place at this year’s Symposium.
-
ContentsNovember 2025 – Contents: Veterinary medicines sessions
The November issue of Regulatory Rapporteur reports on the veterinary medicines sessions from the TOPRA Symposium 2025.
-
Industry newsMHRA cross-agency team outlines emerging considerations for the manufacture of personalised medicines
This industry news update shares the MHRA’s guidance for the manufacture of personalised medicines.
-
JournalDeciphering the regulatory landscape of MENA markets: Challenges in pricing and ancillary issues
The pharmaceutical market in the Middle East and North Africa (MENA) region is growing rapidly, offering vast opportunities for innovation and market expansion. However, navigating the regulatory landscape in this diverse and complex region presents unique challenges that pharmaceutical companies must address in order to create a value proposition.
-
JournalAutogenous vaccines under Regulation (EU) 2019/6
Through Regulation (EU) 2019/6, it has been the first time that so-called autogenous vaccines (AVs) are included in the EU legislation that rules veterinary medicinal products. Described as inactivated vaccines which are manufactured from pathogens obtained from animals in an epidemiological unit, they are restricted to the ...